slotkoers
Korea S.E.
00:00:00 20-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
6.010
KRW
|
-3,53%
|
|
-2,44%
|
-16,30%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
78.785
|
78.457
|
112.394
|
97.444
|
85.441
|
78.348
|
Bedrijfswaarde
1 |
70.163
|
67.012
|
90.216
|
69.618
|
59.106
|
61.660
|
K/w-verhouding
|
12
x
|
20,1
x
|
15,2
x
|
10,8
x
|
7,15
x
|
-15,7
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
1,51
x
|
1,41
x
|
1,68
x
|
1,31
x
|
1,07
x
|
0,96
x
|
Bedrijfswaarde/omzet
|
1,35
x
|
1,21
x
|
1,35
x
|
0,93
x
|
0,74
x
|
0,76
x
|
Bedrijfswaarde/EBITDA
|
15,4
x
|
14,6
x
|
7,28
x
|
5,47
x
|
3,76
x
|
7,28
x
|
Bedrijfswaarde/FCF
|
17,1
x
|
27,2
x
|
9,59
x
|
11,2
x
|
-21,8
x
|
29,5
x
|
FCF Yield
|
5,83%
|
3,68%
|
10,4%
|
8,97%
|
-4,58%
|
3,39%
|
Price to Book
|
1,25
x
|
1,2
x
|
1,58
x
|
1,26
x
|
1
x
|
1
x
|
Aantal aandelen (in duizenden)
|
10.912
|
10.912
|
10.912
|
10.912
|
10.912
|
10.912
|
Referentieprijs
2 |
7.220
|
7.190
|
10.300
|
8.930
|
7.830
|
7.180
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
52.028
|
55.529
|
66.789
|
74.466
|
79.984
|
81.375
|
EBITDA
1 |
4.560
|
4.601
|
12.394
|
12.736
|
15.712
|
8.469
|
Bedrijfsresultaat (EBIT)
1 |
3.527
|
3.416
|
11.039
|
11.266
|
14.329
|
6.720
|
Operationele Marge
|
6,78%
|
6,15%
|
16,53%
|
15,13%
|
17,91%
|
8,26%
|
Resultaat voor belastingen (EBT)
1 |
8.129
|
4.450
|
9.240
|
11.321
|
14.685
|
8.265
|
Nettowinst (verlies)
1 |
6.562
|
3.895
|
7.360
|
9.042
|
11.809
|
-4.917
|
Nettomarge
|
12,61%
|
7,01%
|
11,02%
|
12,14%
|
14,76%
|
-6,04%
|
WPA
2 |
601,8
|
357,3
|
677,4
|
827,6
|
1.095
|
-456,0
|
Free Cash Flow
1 |
4.093
|
2.467
|
9.411
|
6.243
|
-2.709
|
2.092
|
FCF-marge
|
7,87%
|
4,44%
|
14,09%
|
8,38%
|
-3,39%
|
2,57%
|
Kasstroomconversie (ebitda)
|
89,76%
|
53,62%
|
75,93%
|
49,02%
|
-
|
24,71%
|
Kasstroomconversie (nettowinst)
|
62,37%
|
63,34%
|
127,88%
|
69,05%
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
8.621
|
11.446
|
22.178
|
27.826
|
26.335
|
16.688
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
4.093
|
2.467
|
9.411
|
6.243
|
-2.709
|
2.092
|
ROE (netto-inkomsten/eigen vermogen)
|
11%
|
6,09%
|
10,8%
|
12,3%
|
14,6%
|
-6,08%
|
ROA (netto-inkomsten/totale activa)
|
3,15%
|
2,87%
|
8,67%
|
8,19%
|
9,78%
|
4,56%
|
Totale activa
1 |
208.029
|
135.739
|
84.905
|
110.412
|
120.737
|
-107.829
|
Nettoactief per aandeel
2 |
5.759
|
5.971
|
6.507
|
7.112
|
7.855
|
7.147
|
Cashflow per aandeel
2 |
503,0
|
576,0
|
649,0
|
449,0
|
318,0
|
1.084
|
Capex
1 |
1.300
|
3.052
|
738
|
1.146
|
6.093
|
5.814
|
Capex/omzet
|
2,5%
|
5,5%
|
1,11%
|
1,54%
|
7,62%
|
7,14%
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -16,30% | 50,24 mln. | | +21,63% | 44,12 mld. | | +22,99% | 22,71 mld. | | +18,22% | 15,15 mld. | | +12,66% | 13,61 mld. | | +60,18% | 13,34 mld. | | -8,35% | 6,84 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +12,92% | 5,63 mld. |
Generieke geneesmiddelen
|